NBDC Research ID: hum0216.v1

Click to Latest version.

SUMMARY

Aims: To investigate tumor mutation burden for clarification of anti-tumor immuno-response.

Methods: whole exome sequencing analysis

Participants/Materials: 17 patients with lung adenocarcinomas who underwent surgery from 2015-2016

 

Dataset IDType of DataCriteriaRelease Date
JGAS000216 NGS (Exome) Controlled-access (Type I) 2020/02/07

*Release Note

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

JGAS000216

Participants/Materials

lung adenocarcinoma (ICD10: C349): 17 cases

(matched tumor and non-tumor tissues)

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2500]
Library Source DNAs extracted from tumor or non-tumor tissues from lung adenocarcinomas
Cell Lines -
Library Construction (kit name) SureSelect XT Human All Exon system
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp x 2
Japanese Genotype-phenotype Archive Dataset ID JGAD000302
Total Data Volume 230 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Hiroyoshi Nishikawa

Affiliation: Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
The National Cancer Center Research and Development Fund Establishment of an advanced system of immune monitoring 28-A-7
The National Cancer Center Research and Development Fund Development of novel treatment for immunotherapy-resistant cancer 31-A-7
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED) Establishment of predictive methods for cancer immunotherapy based on the evaluation of cancer cells and immune responses JP16cm0106301

 

PUBLICATIONS

TitleDOIDataset ID
1 Blockade of EGFR improves responsiveness to PD1 blockade in EGFR-mutated non-small cell lung cancer doi: 10.1126/sciimmunol.aav3937 JGAD000302
2

 

USRES (Controlled-access Data)

Principal Investigator: Affiliation: Data in Use (Dataset ID)Period of Data Use